Format

Send to

Choose Destination
Exp Cell Res. 2000 May 1;256(2):571-7.

Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity.

Author information

1
Institute of Cancer Biology, Danish Cancer Society, Strandboulevarden 49, Copenhagen O, DK-2100, Denmark.

Abstract

PTEN, a tumor suppressor commonly targeted in human cancer, possesses phosphatase activities toward both protein and lipid substrates. While PTEN suppresses gliomas through cell cycle inhibition which requires its lipid phosphatase activity, PTEN's effects on other tumor types and the role of its protein phosphatase activity are controversial or unknown. Here we show that exogenous wild-type PTEN arrests some, but not all human breast cancer cell lines in G1, in a manner independent of endogenous PTEN. Unexpectedly, the G129E mutant of PTEN selectively deficient in the lipid phosphatase activity still blocked the cell cycle of MCF-7 cells, while the G129R and H123Y mutants lacking both phosphatase activities were ineffective. These results suggest that PTEN's protein phosphatase activity likely contributes to its tumor suppressor function in subsets of tumors and that elucidation of downstream targets which dictate cellular responses to PTEN may have important implications for future cancer treatment strategies.

PMID:
10772829
DOI:
10.1006/excr.2000.4867
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center